New Version of Possible Gene Therapy for Hemophilia B, SPK-9001, Enrolling More Patients in Trial – Hemophilia News Today
Hemophilia News Today |
New Version of Possible Gene Therapy for Hemophilia B, SPK-9001, Enrolling More Patients in Trial
Hemophilia News Today An ongoing Phase 1/2 clinical trial evaluating a gene therapy, SPK-9001, in people with hemophilia B is expanding its enrollment by up to five more patients, who will be given a new version of the therapy, its developer announced. One patient in this … |
